Pediatric non-alcoholic fatty liver disease: New insights and future directions

Table 1 Current and future non-alcoholic fatty liver disease treatment strategies

Present	Under development
Weight loss Physical activity Reduced dietary sucrose intake Reduced dietary fructose intake Reduced dietary omega 6 intake Increased dietary omega 3 intake	Vitamin E Metformin Probiotics Oral treatment with omega 3	Pentoxifylline Farnesoid X receptor agonists Toll-like receptors modifiers Glucagon-like peptid-1 receptor agonists resistant to DPP-4 mediated degradation DPP-4 inhibitors

DPP-4: Dipeptidyl peptidase-4.